Joseph P. Schacht

• University of Colorado, Denver

  Associate professor

Sources: reporter.nih.gov

• National Institute on Drug Abuse

  U01, Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation, U01DA064384, 2025–2028, 18 May 2026

• National Institute on Alcohol Abuse and Alcoholism

  R21, An exploratory randomized controlled trial of the effects of oral semaglutide on alcohol craving and consumption, R21AA031146, 2023–2025, 17 Aug 2023

Sources: reporter.nih.gov